Following on from the “year of the consultation paper”, there are many loose ends to be tied up this year.
Product disclosure proposals seem to ack nowledge that consumers get too much to read but what will replace them? Still more words but FSA-badged?
The shape of the successor regime to polarisation is to be decided. We do not yet know the details of what will be in comparative price tables, although I cannot see them being a substitute for advice whatever happens.
I am also pleased to hear from several IFAs that monitoring teams appear to have had a much more constructive approach to their task in recent months and are actually looking to resolve not create problems. The FSA management should be focusing on continuing with this transformation.
So this year we should see some tying up of loose ends, more indications of whether risk-based regulation actually reduces the burdens on businesses and regulatory intrusiveness and undoubtedly even more consultation documents.